A new method of visualizing acute myocardial infarction in humans following intravenous injection of 15 mCi-5 mg of 99mTc stannous pyrophosphate in 23 patients is reported. Fifteen patients had histories suggestive of acute myocardial infarction and subsequently developed electrocardiogram and enzyme changes that confirmed the clinical diagnosis. Eleven of the 15 patients were scanned 3-5 days postinfarction, and all had positive scintigrams. The four remaining patients were scanned 7-10 days after their myocardial infarction; two had positive scintigrams. In those 8 patients with chest pain but without ECG and enzyme changes suggestive of myocardial infarction, scintigrams were negative. Positive scintigrams in the patients with myocardial infarction are thought to be due to incorporation of pyrophosphate into the crystalline structure of the hydroxyapatite found within the mitochondria of irreversibly damaged myocardial cells. The location of the acute myocardial infarction by scintigram correlated well with ECG localization in the 13 patients with positive scintigrams. This imaging method shows promise in 1) identifying the presence of acute myocardial infarction in patients with chest pain, 2) determining the location of acute myocardial infarction with a high degree of accuracy, 3) detecting the extension of the infarction, and 4) the possibility of determining the size of acute myocardial infarctions.
Additional Indexing Words:
Myocardial imaging C WITH THE ADVENT of new medical and surgical techniques designed to salvage ischemic myocardium, better methods are needed to more quickly and accurately diagnose myocardial infarction and to determine its position and extent in order to evaluate the efficacy of these new techniques. Several radionuclide techniques have been utilized to detect the presence of acute myocardial infarctions.'-However, most of these have the disadvantage of labeling normal myocardium and presenting the infarcted tissue as a void a relatively inefficient method of scintigraphic detection. The high cost of some tracers (such as 43K) and the fact that some re-quire intracoronary injection have limited their clinical usefulness. Technetium-99m (SSmTc)-tagged tetracycline has also shown promise as a positive labeling agent but has the disadvantage of labeling the liver so infarctions involving the diaphragmatic portion of the myocardium are difficult to visualize.5 D'Agostino6 described the localization of calcium ions within the mitochondria of myocardial cells in steroid-induced focal necrosis. D'Agostino and Chiga7 observed that the calcium seemed to be incorporated within a crystalline structure which they believed to be hydroxyapatite. Shen and Jennings8 have described intracellular calcium accumulation in irreversible myocardial cell injury resulting from myocardial infarction. These observations suggest that the 9smTc phosphate bone scanning agents now in common use9' 10 might also be used for scanning acute myocardial infarctions. Consequently, studies were performed in anesthetized dogs with acute myocardial infarction using`smTc stannous pyrophosphate (PYP),* which clearly demonstrated the area of the infarction." In these studies there was no evidence that the intravenously-injected 99mTc PYP The purpose of this report is to describe our initial experience in utilizing`smTc PYP for myocardial imaging in patients with acute myocardial infarction and in patients with chest pain of other etiologies.
Material and Methods
Twenty-three patients admitted to the medical intensive care unit at Parkland Memorial Hospital, Dallas, Texas, with chest pain suggestive of acute myocardial infarction or acute coronary insufficiency were studied. Fifteen of 23 patients were males with the mean age of the entire group being 57.3 years. Scintigrams were performed 3 to 10 days after admission to the hospital when the patients were considered clinically stable. The procedure was fully explained to the patients and all gave their informed consent. In the medical intensive care unit with constant ECG monitoring, each patient was injected intravenously with 15 mCi 99iTc tagged to 5 mg of stannous pyrophosphate. Thirty to 45 minutes later the patient was transported to the Nuclear Medicine Department for myocardial imaging. The patient's ECG was observed throughout transportation on a portable electrocardiograph monitor and defibrillator. No complications or arrhythmias were encountered.
Scintigrams were obtained 45-80 minutes after intravenous injection of the radionuclide. Each patient was imaged in the anterior, lateral, and one or more left anterior oblique projections using a Nuclear-Chicago pho-gamma HP scintillation camera with a 16,000 hole "--high resolution" collimator. The imaging time for 3-5 views was approximately 15 minutes.
Fifteen patients (table 1) with acute myocardial infarction were scanned 3-10 days (mean 5.2 days) following infarction as documented by characteristic electrocardiographic evolution and by diagnostic changes in the serum concentration of the enzymes creatine phosphokinase (CPK), serum glutamic oxaloacetic transaminase (SCOT), and alphahydroxybutyrate dehydrogenase (HBD). The age of these 15 patients ranged from 36 to 78 (mean 56.4) years; 10 of the patients were males.
The remaining 8 patients (table 2) studied were also ad-Circulation, Volume 50, September 1974 mitted to the medical intensive care unit with a diagnosis of possible myocardial infarction. Their ages ranged from 46 to 68 (mean 58.5); 5 patients were males. These patients were imaged 1-4 days after onset of symptoms (mean 2.5 days). None had significant changes of serum CPK, SGOT, or HBD, nor did they evolve electrocardiographic changes of acute myocardial infarction.
Nine of the patients with acute myocardial infarction had repeat scintigrams 16-20 days following the onset of symptoms (mean 18 days).
The scintigrams were graded zero to 4+, depending on the activity over the myocardium. Zero represented no activity ( fig. 1 ); 1+ was questionable activity (fig. 6b); 2+ was definite activity ( fig. 7b ); 3+ and 4+ represented increasing degrees of activity within the infarct (figs. 2, 3, 5). For the purpose of this report, zero and 1+ were considered negative and 2+, 3+, and 4+ were considered positive scintigrams.
The scintillation camera is interfaced to a PDP-81 computer with 12K of core. Images are placed on 7-track magnetic tape for later retrieval and processing. Other peripherals include an ASR-33 teletype, a Tektronix 4002A 
Figure 1
Negative scintigrams of a patient (FL) without acute myocardial infarction shown in A) anterior, B) 450 left anterior oblique, and C) left lateral views. Small arrow points to the sternum with vertebral column indicated hy the large arrow.
graphics terminal for displaying the processed image, and an electrostatic printer-plotter for hard copy.
Results Table 1 demonstrates the relationship between the ECG and scintigraphic localization of the myocardial infarction in the 15 patients with acute myocardial infarction. There was good correlation in all of the patients. The negative scintigram of a patient (FL) without myocardial infarction is shown in figure 1 . Note that the bones show activity, but there is no activity in the myocardium. Two of the patients evolved anterior and anteroseptal infaretions on ECG. In these patients the myocardial scintigram demonstrated corresponding areas of increased activity (figs. 2 and 3). The welllocalized area of 99mTc-PYP is seen to the left of the sternum and rotates as the viewing angle is changed with the anterior surface of the myocardium. One patient (LP) had a lateral infaretion ( fig. 4 ). The localization of 99mTc-PYP in this patient is to the left of the sternum but more lateral and rotates with the lateral aspect of the myocardium. Ten patients had inferior myocardial infarctions on ECG and their scintigrams demonstrated areas of 99mTc-PYP uptake in a characteristic horizontal platelike pattern, perpendicular to and extending leftward from the inferior sternum on the anterior view ( fig. 5 ).
The only 2 patients (BL and DD) with acute myocardial infarction as evidenced by ECG and enzyme changes but negative myocardial scintigrams were scanned 10 and 9 days, respectively, following infarction. We have observed in both patients and animals1' that after 8-10 days`9mTc-PYP myocardial scintigrams either become less positive or are negative.
Nine of the patients with acute myocardial infarction and positive initial scintigrams were rescanned 11-16 days (mean 13.3) later. With one exception, all of these follow-up studies showed less activity in the myocardium than the initial scintigrams (table 3) . Two of the scintigrams became negative ( fig. 6 ); 6 were still positive but demonstrated less activity than the previous scintigrams ( fig. 7 ). One patient (VK) showed an increase in activity. While his scintigrams were positive on the third postinfarction day, the follow-up scintigram showed even more activity on the seventeenth day. He had no symptoms or ECG changes to suggest extension of his infaretion, but he developed pericarditis on the seventh day after infaretion and had a pulmonary embolus on the tenth day after infarction. The reason for the increased activity in the myocardium is unclear.
The scintigrams of the 8 patients who did not have clinical evidence of myocardial infaretion were performed 1-5 days after the onset of symptoms (mean 2.9 days), and all were negative ( fig. 1 ). These scintigrams were done within a time period in which they would be expected to have been positive had myocardial infaretion occurred. Computer processing of the images was not necessary in most of the cases to visualize the infaret, but should be helpful in determining size and exact location in future studies (figs. 2, 3, 5) . Simple background subtraction and contrast enhancement usually improved infaret definition. The rib structures could be removed from the image by using a onedimensional, recursive, band-reject digital filter.
Discussion
We have recently shown that 9emTc stannous pyrophosphate will visualize the area of acute myocardial infaretion in dogs.'1 Imaging studies show that the experimental infaret becomes visible on scintilla-tion camera images beginning approximately 12 to 16 hours following infaretion, and from 30 to 60 minutes after the injection of 99mTc-PYP. Localization persists unchanged for about 4-6 days, but begins to fade thereafter and usually disappears by the fourteenth postinfaretion day. The 99mTe-PYP probably localizes in a crystalline structure, tentatively identified as hydroxyapatite by D'Agostino and found within the mitochondria of irreversibly damaged myocardial cells.6-"
The effectiveness and safety of several of the phosphate "bone scanning" agents, n9mTe-stannouspolyphosphate, 99mTc-stannous-diphosphonate, and 99mTe-stannous pyrophosphate, have been studied by several investigators using experimental ani- mals.9 10, 12, 13 Their studies demonstrated that electrocardiographic changes occur after the injection of 20 mg/kg of these agents. Fletcher et al."1 have shown no changes in serum calcium or phosphorus after injection of about 0.2 mg/kg of 99mTc-PYP in 15 patients in whom bone scintigrams were performed. The dose of 99mTc-PYP (5 mg) utilized in these studies was an average of 0.07 mg/kg, a dose slightly less than onethird of that used by Fletcher. All the patients injected with 99mTc-PYP in this study were on constant ECG monitoring. No patient showed any cardiac rhythm or rate change, or change in ST segments suggestive of myocardial ischemia after the injection. We feel that 15 mCi-5 mg osmTc stannous pyrophosphate is a safe and effective dose for myocardial scanning in patients vith myocardial infaretion. Although`OmTc sfannous pyrophosphate is now limited to investigational use, it should soon become widely available, as have the 99mTe-stannous-polyphosphates and`9mTc-stannousdiphosphonates. These radiopharmaceuticals are inexpensive.
Figure 7
Scintigrnms of CG (same as fig. 2 ) with an anterior wall infarction.
A-B) Anterior views 4 and 18 days postinfarction with arrow indicating the area of damaged myocardium. Note the decrease in radioactivity (4+ to 2+).
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The technique described in this report presents a simple, noninvasive, and safe procedure for documenting the presence of acute myocardial infarction when performed within the first 6 days of symptoms suggestive of myocardial infarction. Although no scintigrams have thus far been done in patients with infarcts earlier than 3 days following infarction, the dog experiments have indicated 1-3 days as the optimal time to image. To date there have been no false positive results. Disease processes in which false positive images might be expected to occur are breast tuimors, functioning breast parenchyma in premenopausal females, and healing rib fractures. Radioactive 99'Tc-PYP is rapidly cleared by the kidneys so little or no blood pool is present in the heart at one hour. If a radiopharmaceutical is cleared from the blood slowly or if renal disease prevents clearance, a radioactive blood pool in the heart at the time of imaging could give rise to false positive scintigrams. The only false negatives in the present study were in 2 patients scanned relatively late after myocardial infaretion at a time when the uptake of 99mTc-PYP by damaged heart muscle had ceased or diminished. 99mTc stannous pyrophosphate does not concentrate in the area of old myocardial infarction11 so this imaging method should be of value in determining if a patient with an abnormal ECG has an acute myocardial infarction. However, some scintigrams in patients with acute myocardial infarcts have remained faintly positive for several weeks. How long it will take for some of the scintigrams to become entirely negative, or if some of them ever do become entirely negative, will have to be determined by future studies. The myocardial imaging technique described in this report appears to represent a valuable tool not only for establishing the presence or absence of acute myocardial infarction, but for estimating the size of the area damaged by the myocardial infarction and hopefully the effect of various therapeutic measures on the size and progression of myocardial infarcts. However, larger numbers of patients need to be studied to determine whether inflammatory processes such as pericarditis and infiltrative myocardial diseases also result in abnormal scintigrams and to investigate in a larger number of patients the time course of positive scintigrams after acute myocardial infarction.
